Results 151 to 160 of about 172,507 (213)

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

Hepatology, 2016
Z. Younossi, D. Blissett, Robert S Blissett, L. Henry, M. Stepanova, Youssef Younossi, A. Racila, S. Hunt, R. Beckerman   +8 more
semanticscholar   +1 more source

Increased risk of nonalcoholic fatty liver disease in patients with thyroid cancer: a nationwide cohort study. [PDF]

BMC Cancer
Cho YB, Park KS.
europepmc   +1 more source

Nonalcoholic Fatty Liver Disease

Canadian Journal of Gastroenterology and Hepatology, 2018
Branka Filipović, Alastair Forbes, Bojan Tepeš, Dan L. Dumitraşcu   +3 more
doaj   +1 more source

Efficacy of different interventions for nonalcoholic fatty liver disease: A meta-analysis of lifestyle modifications, silymarin, and medications. [PDF]

Asia Pac J Clin Nutr
Zhang Z, Li S, Sun J.
europepmc   +1 more source

Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis

Hepatology, 2017
Guangqin Xiao, Sixian Zhu, Xiao Xiao, Lunan Yan, Jiayin Yang, Gang Wu   +5 more
semanticscholar   +1 more source

What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development? [PDF]

World J Gastroenterol
Pan Q, Xu QY, Zhang LH, He YF.
europepmc   +1 more source

IMM‐H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high‐fat diet

, 2017
Huijie Shi, Qingchun Wang, Yang Liu, Shouxia Xie, Haibo Zhu   +4 more
openalex   +1 more source

Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease. [PDF]

Diabetol Metab Syndr
Yang L, Huang H, Wang Z, Xu C.
europepmc   +1 more source

Triglyceride-glucose index associated with anthropometric parameters: Early markers in the progression of nonalcoholic fatty liver disease. [PDF]

Hepatol Forum
da Silva ES, Locatelli C.
europepmc   +1 more source